Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Orzeyful (oveporexton)FDA approves Orzeyful (oveporexton)5 August 2026The FDA approved Orzeyful (oveporexton), a drug from Takeda Pharms Usa. Form: Tablet, Oral. Granted priority review, reserved for treatments that would be a significant improvement over what exists. Application NDA220860.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)